AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 77 filers reported holding AKCEA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $258,000 | +32.3% | 14,200 | 0.0% | 0.00% | – |
| Q2 2020 | $195,000 | -3.9% | 14,200 | 0.0% | 0.00% | – |
| Q1 2020 | $203,000 | -15.8% | 14,200 | 0.0% | 0.00% | – |
| Q4 2019 | $241,000 | +10.0% | 14,200 | 0.0% | 0.00% | – |
| Q3 2019 | $219,000 | -34.2% | 14,200 | 0.0% | 0.00% | – |
| Q2 2019 | $333,000 | -17.2% | 14,200 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $402,000 | -6.1% | 14,200 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $428,000 | -13.9% | 14,200 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $497,000 | +47.5% | 14,200 | 0.0% | 0.00% | – |
| Q2 2018 | $337,000 | -11.1% | 14,200 | -4.1% | 0.00% | – |
| Q1 2018 | $379,000 | -13.5% | 14,800 | -41.3% | 0.00% | -100.0% |
| Q4 2017 | $438,000 | -45.9% | 25,209 | -13.9% | 0.00% | 0.0% |
| Q3 2017 | $810,000 | – | 29,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,100,768 | $72,713,000 | 1.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $743,000 | 0.28% |
| Motley Fool Asset Management LLC | 63,591 | $1,491,000 | 0.17% |
| ALTRINSIC GLOBAL ADVISORS LLC | 120,286 | $2,821,000 | 0.13% |
| Virtus ETF Advisers LLC | 11,730 | $275,000 | 0.06% |
| Hudson Bay Capital Management LP | 80,000 | $1,876,000 | 0.04% |
| FMR LLC | 12,239,489 | $287,016,000 | 0.03% |
| ALPS ADVISORS INC | 193,375 | $4,535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 11,925 | $280,000 | 0.03% |
| Sculptor Capital LP | 400,200 | $9,384,000 | 0.02% |